J. Albers

发表

Flow cytometric and cytophotometric DNA analysis cannot predict subsequent tumour recurrence in pathological stage IIA/B non-seminomatous testicular germ cell tumour patients who do not receive adjuvant chemotherapy.

O. Cummings, P. Albers, J. Donohue, 1995, European journal of cancer.

Mouse genetic background influences whether HrasG12V expression plus Cdkn2a knockdown causes angiosarcoma or undifferentiated pleomorphic sarcoma

P. Wild, I. Frew, A. F. Gonçalves, 2018, Oncotarget.

Tumor proliferative activity is predictive of pathological stage in clinical stage A nonseminomatous testicular germ cell tumors.

P. Albers, T. Ulbright, J. Baniel, 1996, The Journal of urology.

Oncogenic HrasG12V expression plus knockdown of Cdkn2a using ecotropic lentiviral vectors induces high-grade endometrial stromal sarcoma

P. Wild, I. Frew, A. Catalano, 2017, PloS one.

Combined mutation of Vhl and Trp53 causes renal cysts and tumours in mice

H. Moch, P. Schraml, P. Wild, 2013, EMBO molecular medicine.

A versatile modular vector system for rapid combinatorial mammalian genetics.

P. Wild, S. Brandt, M. Rechsteiner, 2015, The Journal of clinical investigation.

ATR represents a therapeutic vulnerability in clear cell renal cell carcinoma

P. Seidel, M. Boerries, D. von Elverfeldt, 2022, JCI insight.

Sensitivity and Resistance of Oncogenic RAS-Driven Tumors to Dual MEK and ERK Inhibition

P. Seidel, P. Wild, T. Brummer, 2021, Cancers.

The Preclinical Pharmacology of Tepotinib—A Highly Selective MET Inhibitor with Activity in Tumors Harboring MET Alterations

C. Stroh, N. Karachaliou, A. Clark, 2023, Molecular cancer therapeutics.

Overcoming MET-mediated resistance in oncogene-driven NSCLC

N. Karachaliou, Nadine Reischmann, M. Molina-Vila, 2023, iScience.

Discovery of Cycloalkyl[c]thiophenes as Novel Scaffolds for Hypoxia-Inducible Factor-2α Inhibitors.

M. Nowak, D. Musil, Liming Dong, 2023, Journal of medicinal chemistry.